Cigna Corp vs Johnson & Johnson — how do they compare? Cigna Corp trades at $273 (market cap $73.56B), while Johnson & Johnson trades at $259 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 8.5× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | JNJ | |
|---|---|---|
Market Cap | $73.56B | $626.09B |
Sector | Health | Health |
52-Week High | $311.00 | $267.24 |
52-Week Low | $244.41 | $172.78 |
Enterprise Value | $98.27B | $654.37B |
Dividend Yield | 2.24% | 2.06% |
Volume | — | 6,156,228 |
Trailing returns across standard periods
Latest headlines on both assets
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →